Incidence of Intraoperative Vasoplegic Syndrome in Lung Transplantation.

bilateral lung transplantation cardiopulmonary bypass cardiothoracic anesthesia cardiothoracic surgery cystic fibrosis lung transplantation vasoplegia vasoplegic syndrome

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
12 2023
Historique:
received: 15 05 2023
revised: 16 08 2023
accepted: 17 08 2023
medline: 6 11 2023
pubmed: 30 9 2023
entrez: 29 9 2023
Statut: ppublish

Résumé

Severe hypotension and low systemic vascular resistance in the setting of adequate cardiac output, known as "vasoplegic syndrome" (VS), is a physiologic disturbance reported in 9% to 44% of cardiac surgery patients. Although this phenomenon is well-documented in cardiac surgery, there are few studies on its occurrence in lung transplantation. The goal of this study was to characterize the incidence of VS in lung transplantation, as well as identify associated risk factors and outcomes. Retrospective study of single and bilateral lung transplants from April 2013 to September 2021. The study was conducted at an academic hospital. Patients ≥18 years of age who underwent lung transplantation. None. The authors defined VS as mean arterial pressure <65 mmHg, cardiac index ≥2.2 L/min/m The incidence of VS in lung transplantation is comparable to that of cardiac surgery. Interestingly, male sex and cystic fibrosis are strong risk factors. Identifying lung transplant recipients at increased risk of VS may be crucial to anticipating intraoperative complications.

Identifiants

pubmed: 37775341
pii: S1053-0770(23)00711-5
doi: 10.1053/j.jvca.2023.08.136
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2531-2537

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest E. Methangkool receives consulting fees from Edwards LifeSciences and author royalties from UpToDate, Inc.

Auteurs

Stephanie Lam (S)

Department of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.

Sean Mofidi (S)

Department of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.

Louis Saddic (L)

Department of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.

Jacques Neelankavil (J)

Department of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.

Theodora Wingert (T)

Department of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.

Drew Cheng (D)

Department of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.

Tristan Grogan (T)

Department of Medicine Statistics Core, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA.

Emily Methangkool (E)

Department of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA. Electronic address: emethangkool@mednet.ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH